BASE

¿Qué es BASE?

BASE es una solución de lavado capaz de eliminar los antibióticos de diferentes tejidos de origen humano destinados al trasplante (cardiovascular, musculoesquelético, osteotendineo, piel y membrana amniótica), después de la descontaminación.

La solución también elimina los residuos de DMSO de los tejidos, después de la crioconservación y preserva la integridad de los tejidos, debido a la fórmula de propiedad de Alchimia basada en RPMI 1640.

La solución de lavado BASE también puede utilizarse para el transporte del tejido al banco o durante la disección del tejido.

Uso previsto

LAVADO Y TRANSPORTE DE TEJIDOS (CARDIOVASCULAR, MUSCULOESQUELÉTICO, OSTEOTENDINEO, PIEL Y MEMBRANA AMNIÓTICA)

Características

ESTÉRIL
APIRÓGENO
SIN MYCOPLASMA
MARCA CE: 0477

Documentos Técnicos

Certificado CE 335.83 KB 467 downloads

AL.CHI.MI.A. S.R.L. production quality system is compliant with Annex Il (excluding...

Descargar

Ficha Técnica - BAS 007-00 461.30 KB 152 downloads

BASE - 500 ml ...

Descargar

Videos Quirúrgicos

BASE – Rinsing of tissue processed

Publicaciones y Presentaciones

Logistics of an advanced therapy medicinal product during COVID-19 pandemic in Italy: successful delivery of mesenchymal stromal cells in dry ice
Año: 2020Autores: Astori G.; Bernardi M.; Bozza A.; Catanzaro D.; Chieregato K.; Merlo A.; Santimaria M.; Barbazza R.; Amodeo G.; Ciccocioppo R.; Elice F.; Ruggeri M. J Transl Med 18, 451 (2020)doi.org/10.1186/s12967-020-02625-0Online version Esta es una: Publicación Abstract Serious intraocular [...]
Establishing a procedure for dimethyl sulfoxide removal from cardiovascular allografts: a quantitative study
Año: 2013Autores: Gatto C.; Dainese L.; Buzzi M.; Terzi A.; Guarino A.; Pagliaro P.P.; Polvani G.; D’Amato Tothova J. Cell and Tissue Banking 14(2): 205-12, 2013 Online version Esta es [...]
A suitable and efficient procedure for the removal of decontaminating antibiotics from tissue allografts
Año: 2013Autores: Gatto C.; Giurgola L.; D’Amato Tóthová J. Cell and Tissue Banking 14(1), 107-115, 2013 Online version Esta es una: Publicación Abstract: The presence of residual antibiotics in tissue [...]
Establishment of a rinsing procedure to eliminate antibiotic and glycerol residues from cryopreserved skin decontaminated with BASE.128
Año: 2011, EATB Autores: Pianigiani E.; Gatto C.; Giurgola L.; D’Amato Tóthová, J. Abstract: Skin decontamination and cryopreservation can result in the presence of antibiotic and glycerol residues, which shall be removed before [...]
Optimization of cardiovascular tissue decontamination and rinsing with BASE.128 and BASE
Año: 2011, EATB Autores: Terzi A.; Buzzi M.; Guarino A.; Dainese L.; Vasuri F., D’Amato Tóthová J.; Gatto C. Abstract: We studied the optimal conditions to decontaminate and rinse cardiovascular tissues intended for transplantation [...]
Removal of Me2SO from cryopreserved skin and heart valves CRYO 2010
Año: 2010, CRYO Autores: Gatto C.; Marchiani A.; Ruzza P.; Beccaro M.; D’Amato Tóthová J. Abstract: Elimination of Me2SO from cryopreserved allografts is one of the crucial steps in tissue processing phases in order to [...]
Elimination of antibiotic carry-over from tissues decontaminated with Base.128
Año: 2010, EATB Autores: Gatto C.; Beccaro M.; Lipartiti M.; D’Amato Tóthová J. Abstract: Decontamination of tissue allografts in antibiotic cocktails can lead to the antibiotic carry-over effect, which in turn can result in [...]
Removal of DMSO from cryopreserved human skin
Año: 2010, EATB Autores: Vassanelli A.; Gatto C.; Bosinelli A.; Rizzi S.; Marchiani A.; Ruzza P.; D’Amato Tóthová J.; Aprili G. Abstract: Elimination of DMSO from cryopreserved skin allografts is one of the [...]
Removal of DMSO from cardiovascular allografts
Año: 2010, EATB Autores: Guarino A.; Gatto C.; Dainese L.; Buzzi M.; Pagliaro P.; D’Amato Tóthová J.; Polvani G.L. Abstract: Elimination of DMSO from cryopreserved allografts is one of the crucial steps in tissue [...]
Comparison among the medical devices BASE.128, BASE, CRYO.ON and the solutions currently used in two Italian cardiovascular tissue banks
Año: 2010, EATB Autores: Gatto C.; Marchiani A.; Ruzza P.; Beccaro M.; D’Amato Tóthová, J. Abstract: We evaluated the performances of the HTP medical devices in comparison with solutions currently used by the Cardiovascular [...]

Productos relacionados

View Cart

Details

BASE 128

Embalaje: Botella
Artículos: 1
Volumen: 250 ml, 500 ml

BASE•128 es una solución lista para la descontaminación de diversos tejidos humanos destinados al trasplante (cardiovascular, musculoesquelético, osteotendineo, piel y membrana amniótica) en [...]
Category: Bancos de tejidosDescontaminación de tejidos

¿Qué es BASE?

Uso previsto

Características

Documentos Técnicos

Certificado CE 335.83 KB 467 downloads

Ficha Técnica - BAS 007-00 461.30 KB 152 downloads

Videos Quirúrgicos

Publicaciones y Presentaciones

Logistics of an advanced therapy medicinal product during COVID-19 pandemic in Italy: successful delivery of mesenchymal stromal cells in dry ice

Establishing a procedure for dimethyl sulfoxide removal from cardiovascular allografts: a quantitative study

A suitable and efficient procedure for the removal of decontaminating antibiotics from tissue allografts

Establishment of a rinsing procedure to eliminate antibiotic and glycerol residues from cryopreserved skin decontaminated with BASE.128

Optimization of cardiovascular tissue decontamination and rinsing with BASE.128 and BASE

Removal of Me2SO from cryopreserved skin and heart valves CRYO 2010

Elimination of antibiotic carry-over from tissues decontaminated with Base.128

Removal of DMSO from cryopreserved human skin

Removal of DMSO from cardiovascular allografts

Comparison among the medical devices BASE.128, BASE, CRYO.ON and the solutions currently used in two Italian cardiovascular tissue banks

Productos relacionados

BASE 128

Solicitar información sobre BASE

Solicitar información sobre BASE

CRYO.ON

GLYO.ON

BASE 128

Cirugía Oftálmica

Banco de tejidos humanos

Buscar

Compañía

Sede